Article
Loss of GDF-15 abolishes sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer.
Journal of cancer research and clinical oncology - 1 Apr 2010
Zimmers Teresa A, Gutierrez Juan C, Koniaris Leonidas G
Abstract excerpt
BACKGROUND: Growth-differentiation factor (GDF)-15, a member of the TGF-beta superfamily, is potently induced in the intestine following mechanical injury, genotoxic insult and following non-steroidal anti-inflammatory drugs (NSAIDs) exposure. GDF-15 expression correlates with apoptosis in intestinal cells and has been implicated in the pathogenesis of colorectal cancer formation and the anti-tumor effects of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
